Ustekinumab Biosimilar - Research Grade,ichor.bio,ICH4034

Detects human IL-12 and IL-23. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ustekinumab.

Host

Humanized

Reactivity

Human

Platform ID

BAB015124444

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications
Scientific Background
Synonyms

Specifications

NameUstekinumab Biosimilar - Research Grade
Cat. No.ICH4034
HostHumanized
IsotypeHuman IgG1 Kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetIL-12 and IL-23
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml ICH3002-100ml ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only

Scientific Background

Ustekinumab is a human IgG1_ monoclonal antibody against the p40 subunit of the IL-12 and IL-23 cytokines. Using DNA recombinant technology, ustekinumab is produced in a well characterized recombinant cell line and is purified using standard bio-processin

Synonyms

Interleukin-12, Interleukin-23

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.